Drug profile · INN
regadenoson
RAPISCAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
regadenoson (RAPISCAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN regadenoson
Brand RAPISCAN
Route INTRAVENOUS
Formulation SOLUTION
ATC code C01EB21
Frequently asked questions
What is regadenoson?
regadenoson (RAPISCAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for regadenoson?
RAPISCAN is a marketed brand name for regadenoson. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of regadenoson?
regadenoson has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.